Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT)
1 clinical trials · Condition
◉ Watch Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT)
| Record | Firm | Date |
|---|---|---|
| Lenalidomide and Low-dose Cyclophosphamide for MALT Lymphoma (NCT04604028) | National Taiwan University Hospital | 2020-11-10 |
Track Refractory Extranodal Marginal Zone B-Cell Lymphoma (MALT) automatically
Every clearance here is in the API, with alerts when new ones post.